Emerging pathology: Pulmonary disease caused by Mycobacterium xenopi - a challenge in clinical practice

Introduction. Human nontuberculous mycobacteria (NTM) or environmental mycobacteria related disease is on increase. Risk factors are unclear and associations are observed in relation to climate differences, population density, or host susceptibility. With availability of molecular techniques for NTM...

Full description

Saved in:
Bibliographic Details
Main Authors: Pešut Dragica P., Stević Ruža S., Marić-Živković Jasmina Đ., Savić Biljana Đ., Nagorni-Obradović Ljudmila M.
Format: Article
Language:English
Published: Ministry of Defence of the Republic of Serbia, University of Defence, Belgrade 2018-01-01
Series:Vojnosanitetski Pregled
Subjects:
Online Access:http://www.doiserbia.nb.rs/img/doi/0042-8450/2018/0042-84501700026P.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850227969083047936
author Pešut Dragica P.
Stević Ruža S.
Marić-Živković Jasmina Đ.
Savić Biljana Đ.
Nagorni-Obradović Ljudmila M.
author_facet Pešut Dragica P.
Stević Ruža S.
Marić-Živković Jasmina Đ.
Savić Biljana Đ.
Nagorni-Obradović Ljudmila M.
author_sort Pešut Dragica P.
collection DOAJ
description Introduction. Human nontuberculous mycobacteria (NTM) or environmental mycobacteria related disease is on increase. Risk factors are unclear and associations are observed in relation to climate differences, population density, or host susceptibility. With availability of molecular techniques for NTM identification, we faced emergence of NTM pulmonary cases. The work is an invitation more to colleagues to enroll the rare NTM cases into large study group. Case report. During an episode of productive cough and fever in a 73-year-old HIV-negative man smoker with minimal sequellae of pulmonary tuberculosis, sputum smears were acid fast bacilli positive on direct microscopy. The Löwenstein- Jensen culture results were positive with 20, 30 and 50 colonies, and molecular identification confirmed Mycobacterium xenopi (M. xenopi). Standard chest radiography showed no signs of active lesions. Examination was completed with bronchoscopy and thorax multi-slice computed tomography (MSCT). Cavitary lesions in the apico-posterior part of the left upper lobe (LUL) were detected. Under treatment (rifampicin, ethambutol, clarithromycin) sputum conversion was achieved, but irregular cavitation in the LUL remained at MSCT after 6 and after 12 months with signs of minimal regression. Patient’s general condition only mildly improved and asthenia remained. Observed risk factors were previous pulmonary disease, tobacco smoking, malnutrition and prolonged emotional stress. Conclusion. M. xenopi related pulmonary disease, difficult to cure and with uncertain prognosis, is a challenge in clinical practice. Since treatment is still controversial, more randomized clinical trials are needed. Current international multicentre approach might be a good option for a larger sample size and development of new guide.
format Article
id doaj-art-fd6abfc0b7584eb685144ef061a52f32
institution OA Journals
issn 0042-8450
2406-0720
language English
publishDate 2018-01-01
publisher Ministry of Defence of the Republic of Serbia, University of Defence, Belgrade
record_format Article
series Vojnosanitetski Pregled
spelling doaj-art-fd6abfc0b7584eb685144ef061a52f322025-08-20T02:04:40ZengMinistry of Defence of the Republic of Serbia, University of Defence, BelgradeVojnosanitetski Pregled0042-84502406-07202018-01-0175994995310.2298/VSP151224026P0042-84501700026PEmerging pathology: Pulmonary disease caused by Mycobacterium xenopi - a challenge in clinical practicePešut Dragica P.0Stević Ruža S.1Marić-Živković Jasmina Đ.2Savić Biljana Đ.3Nagorni-Obradović Ljudmila M.4Faculty of Medicine, Belgrade + Clinical Centre of Serbia, Teaching Hospital of Pulmonology, BelgradeFaculty of Medicine, Belgrade + Centre of Radiology and Magnetic Resonance, BelgradeClinical Centre of Serbia, Teaching Hospital of Pulmonology, BelgradeClinical Centre of Serbia, Teaching Hospital of Pulmonology, BelgradeFaculty of Medicine, Belgrade + Clinical Centre of Serbia, Teaching Hospital of Pulmonology, BelgradeIntroduction. Human nontuberculous mycobacteria (NTM) or environmental mycobacteria related disease is on increase. Risk factors are unclear and associations are observed in relation to climate differences, population density, or host susceptibility. With availability of molecular techniques for NTM identification, we faced emergence of NTM pulmonary cases. The work is an invitation more to colleagues to enroll the rare NTM cases into large study group. Case report. During an episode of productive cough and fever in a 73-year-old HIV-negative man smoker with minimal sequellae of pulmonary tuberculosis, sputum smears were acid fast bacilli positive on direct microscopy. The Löwenstein- Jensen culture results were positive with 20, 30 and 50 colonies, and molecular identification confirmed Mycobacterium xenopi (M. xenopi). Standard chest radiography showed no signs of active lesions. Examination was completed with bronchoscopy and thorax multi-slice computed tomography (MSCT). Cavitary lesions in the apico-posterior part of the left upper lobe (LUL) were detected. Under treatment (rifampicin, ethambutol, clarithromycin) sputum conversion was achieved, but irregular cavitation in the LUL remained at MSCT after 6 and after 12 months with signs of minimal regression. Patient’s general condition only mildly improved and asthenia remained. Observed risk factors were previous pulmonary disease, tobacco smoking, malnutrition and prolonged emotional stress. Conclusion. M. xenopi related pulmonary disease, difficult to cure and with uncertain prognosis, is a challenge in clinical practice. Since treatment is still controversial, more randomized clinical trials are needed. Current international multicentre approach might be a good option for a larger sample size and development of new guide.http://www.doiserbia.nb.rs/img/doi/0042-8450/2018/0042-84501700026P.pdflung diseasesMycobacterium xenopirisk factorsdiagnosisdrug therapycombinationantibioticstreatment outcome
spellingShingle Pešut Dragica P.
Stević Ruža S.
Marić-Živković Jasmina Đ.
Savić Biljana Đ.
Nagorni-Obradović Ljudmila M.
Emerging pathology: Pulmonary disease caused by Mycobacterium xenopi - a challenge in clinical practice
Vojnosanitetski Pregled
lung diseases
Mycobacterium xenopi
risk factors
diagnosis
drug therapy
combination
antibiotics
treatment outcome
title Emerging pathology: Pulmonary disease caused by Mycobacterium xenopi - a challenge in clinical practice
title_full Emerging pathology: Pulmonary disease caused by Mycobacterium xenopi - a challenge in clinical practice
title_fullStr Emerging pathology: Pulmonary disease caused by Mycobacterium xenopi - a challenge in clinical practice
title_full_unstemmed Emerging pathology: Pulmonary disease caused by Mycobacterium xenopi - a challenge in clinical practice
title_short Emerging pathology: Pulmonary disease caused by Mycobacterium xenopi - a challenge in clinical practice
title_sort emerging pathology pulmonary disease caused by mycobacterium xenopi a challenge in clinical practice
topic lung diseases
Mycobacterium xenopi
risk factors
diagnosis
drug therapy
combination
antibiotics
treatment outcome
url http://www.doiserbia.nb.rs/img/doi/0042-8450/2018/0042-84501700026P.pdf
work_keys_str_mv AT pesutdragicap emergingpathologypulmonarydiseasecausedbymycobacteriumxenopiachallengeinclinicalpractice
AT stevicruzas emergingpathologypulmonarydiseasecausedbymycobacteriumxenopiachallengeinclinicalpractice
AT mariczivkovicjasminađ emergingpathologypulmonarydiseasecausedbymycobacteriumxenopiachallengeinclinicalpractice
AT savicbiljanađ emergingpathologypulmonarydiseasecausedbymycobacteriumxenopiachallengeinclinicalpractice
AT nagorniobradovicljudmilam emergingpathologypulmonarydiseasecausedbymycobacteriumxenopiachallengeinclinicalpractice